Journal article
Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials
- Abstract:
-
STUDY QUESTION: How important was the change in lumbar spine (L1–L4), femoral neck, and total hip bone mineral density (BMD) from post-treatment baseline values to 24 months after the end of treatment in PRIMROSE 1 and PRIMROSE 2 study participants? SUMMARY ANSWER: In the present study (PRIMROSE 3), mean percentage changes in lumbar spine BMD from the post-treatment baseline to month 24 (primary endpoint) were small in most treatment groups and similar to variations in the placebo group. WHAT...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.4MB, Terms of use)
-
- Publisher copy:
- 10.1093/hropen/hoaf025
Authors
- Publisher:
- Oxford University Press
- Journal:
- Human Reproduction Open More from this journal
- Volume:
- 2025
- Issue:
- 3
- Article number:
- hoaf025
- Publication date:
- 2025-05-13
- DOI:
- EISSN:
-
2399-3529
- ISSN:
-
2399-3529
- Language:
-
English
- Keywords:
- Pubs id:
-
2131797
- Local pid:
-
pubs:2131797
- Source identifiers:
-
3058200
- Deposit date:
-
2025-06-27
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record